Skip to ContentSkip to Navigation
Practical matters How to find us dr. L.C. Steggink

Publications

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50years

Long-term outcome and treatment-related toxicity in patients with breast and testicular cancer

Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors: A Cross-Sectional Study

Genome-wide association study of cardiovascular disease in testicular cancer patients treated with platinum-based chemotherapy

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy

Cardiac Function After Radiation Therapy for Breast Cancer

Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment

High-dose chemotherapy (HDCT) with hematopoietic stem cell transplantation (HSCT) in high-risk breast cancer (BC) patients with ≥4 involved axillary lymph nodes (ALN): 20-year follow-up of a randomized phase 3 study,: Proffered paper (oral presentation) 187O

Read more